� Imaging

If the patient has a ROSC, obtain a chest x-ray to evaluate

endotracheal tube placement and an electrocardiogram to

evaluate for cardiac ischemia.

PROCEDURES

Pericardiocentesis is indicated if there is a suspicion of

cardiac tamponade in the setting of PEA. Bedside ultra ­

sound can be useful if tamponade is suspected. A long

spinal needle is inserted s ubxiphoid into the pericardia! sac

aimed toward the left shoulder. Pull back on a 60-mL

syringe while advancing the needle until blood is obtained.

A needle thoracostomy is indicated if there is a s uspicion of tension pneumothorax in the setting of PEA. I nsert

an 1 8-gauge needle into the second intercostals space in

the midclavicular line. A needle thoracostomy must always

be followed by a tube thoracostomy in patients with

ROSC.

MEDICAL DECISION MAKING

The differential diagnosis for SCD is broad. Management

of SCD depends on the presenting rhythm; however, every

patient should receive continuous high-quality uninterrupted chest compressions. Defibrillate VF/pulseless VT.

Administer epinephrine for asystole and PEA. Attempt to

correct reversible causes of PEA, the H's, and T's

(Table 10-1). Once ROSC occurs, initiate postresuscitative

care, including therapeutic hypothermia, which improves

neurologic outcome.

Table 1 0-1. The H's and T's of PEA.

Hypoxia

Hypovolemia

Hydrogen ion (acidosis)

Hypo-/hyperkalemia

Hypothermia

Toxins

Tamponade (cardiac)

Tension pneumothorax

Thrombosis (pulmonary, cardiac)

TREATMENT

If there is a clear, written, advanced directive signed by the

patient or medical power of attorney stating that resuscitative efforts should not be instituted, or if the resuscitation

would be futile because of clear signs of irreversible death

(decapitation, rigor mortis), resuscitative efforts should

not be initiated or continued.

The resuscitative team must orchestrate simultaneous

assessment and management of patients in cardiopulmo ­

nary arrest.

1. Defibrillation. Indicated for patients in VF or pulseless

VT. The rate of successful defibrillation when attempted

within 1 minute of VT is >90o/o, but falls lOo/o with each

subsequent minute.

Comments

Search This Blog

Archive

Show more

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

ZENOXIA 15 MG, Comprimé

VOXCIB 200 MG, Gélule

Kana Brax Laberax

فومي كايند

بعض الادويه نجد رموز عليها مثل IR ، MR, XR, CR, SR , DS ماذا تعني هذه الرموز

NIFLURIL 700 MG, Suppositoire adulte

Antifongiques مضادات الفطريات

Popular posts from this blog

علاقة البيبي بالفراولة بالالفا فيتو بروتين

التغيرات الخمس التي تحدث للجسم عند المشي

إحصائيات سنة 2020 | تعداد سكَان دول إفريقيا تنازليا :

ما هو الليمونير للأسنان ؟

ACUPAN 20 MG, Solution injectable

CELEPHI 200 MG, Gélule

الام الظهر

VOXCIB 200 MG, Gélule

ميبستان

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

ZENOXIA 15 MG, Comprimé

VOXCIB 200 MG, Gélule

Kana Brax Laberax

فومي كايند

بعض الادويه نجد رموز عليها مثل IR ، MR, XR, CR, SR , DS ماذا تعني هذه الرموز

NIFLURIL 700 MG, Suppositoire adulte

Antifongiques مضادات الفطريات

Popular posts from this blog

Kana Brax Laberax

TRIPASS XR تري باس

PARANTAL 100 MG, Suppositoire بارانتال 100 مجم تحاميل

الكبد الدهني Fatty Liver

الم اسفل الظهر (الحاد) الذي يظهر بشكل مفاجئ bal-agrisi

SEDALGIC 37.5 MG / 325 MG, Comprimé pelliculé [P] سيدالجيك 37.5 مجم / 325 مجم ، قرص مغلف [P]

نمـو الدمـاغ والتطـور العقـلي لـدى الطفـل

CELEPHI 200 MG, Gélule

أخطر أنواع المخدرات فى العالم و الشرق الاوسط

Archive

Show more